Related Experiment Video
Updated: Jun 1, 2026
15:18
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Pain management in the pediatric population
1Pain Management Department, Children's Medical Center Dallas, TX 75235, USA. LYNN.CLARK@childrens.com
Critical Care Nursing Clinics of North America
|June 1, 2011
Summary
Effective pain management in children is crucial for healthcare. Nurses must accurately assess and treat pain, especially for infants in neonatal intensive care units (NICUs), to ensure optimal patient outcomes.
Area of Science:
- Pediatric Healthcare
- Pain Management Science
Background:
- Pain management is a critical component of pediatric healthcare.
- Pain prevalence in children varies significantly based on their health status.
- Healthy children undergo numerous immunizations, while those in neonatal intensive care units (NICUs) experience hundreds of painful procedures.
Purpose of the Study:
- To emphasize the importance of pain assessment and treatment in pediatric care.
- To highlight the unique challenges in managing pain for critically ill infants.
Main Methods:
- This abstract does not detail specific methods.
- It focuses on the prevalence and necessity of pain management in pediatric populations.
Main Results:
- Children, particularly those in NICUs, face a high incidence of painful encounters.
- The frequency of pain is directly linked to a child's health condition and medical interventions.
Conclusions:
- Nurses require specialized knowledge to effectively assess and manage pain in children.
- Optimal pain treatment is an essential aspect of quality pediatric healthcare.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...